Literature DB >> 18090121

Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women.

Theodoros Agorastos1, Nikolaos Papadopoulos, Alexandros F Lambropoulos, Sofia Chrisafi, Themistoklis Mikos, Dimitrios G Goulis, Theodoros C Constantinidis, Alexandros Kotsis, John N Bontis.   

Abstract

The aim of the study was to determine the importance of genetic polymorphisms of glutathione-S-transferase T1 and M1 and cytochrome P1A1 genes in the development of cervical intraepithelial neoplasia in Greek women. This was a prospective, case-control study conducted by the Cervical Pathology and Colposcopy Unit of a University Ob/Gyn Department from 1999 to 2003. Cervical smears from 114 controls without any cytological and/or colposcopical evidence of cervical pathology and from 166 women with history of cervical intraepithelial neoplasia (56 CIN I, 54 CIN II and 56 CIN III) were examined with polymerase chain reaction for the above-mentioned genetic polymorphisms, taking also in mind their smoking attitudes. Statistical analysis was performed to detect any association between the null genotype of GSTM1 and GSTT1 genes and the CYP1A1 m1 polymorphism and the severity of cervical intraepithelial neoplasia. The distributions of the GSTT1 and GSTM1 wild-type genotypes were 57.48 and 39.75%, respectively. No woman with homozygous GSTT1 and GSTM1 null/null genotype was identified. CYP1A1 m1 polymorphism frequency was 24.49%. No woman with homozygous CYP1A1 m1/m1 genotype was detected as well. No significant difference in the frequencies of the GSTM1 and GSTT1 null alleles, and the CYP1A1 m1 polymorphism, was found between cases and controls. After application of Mantel-Haenszel chi procedure, there was no linear severity of the lesion and the frequency of these polymorphisms. According to our results, glutathione-S-transferase T1 and M1 and cytochrome P1A1 genetic polymporphisms do not appear to be a risk factor for cervical disease irrespective of smoking habits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18090121     DOI: 10.1097/01.cej.0000243859.99265.92

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  6 in total

Review 1.  Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.

Authors:  Liangbin Xia; Jing Gao; Yan Liu; Ke Wu
Journal:  Tumour Biol       Date:  2012-10-04

2.  Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos; Souzana Choussein; Nikos F Vlahos
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

3.  CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis.

Authors:  Shuyan Yang; Changru Jia; Hong Zhu; Shiyu Han
Journal:  Tumour Biol       Date:  2012-09-05

4.  Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis.

Authors:  Lin-Bo Gao; Xin-Min Pan; Li-Juan Li; Wei-Bo Liang; Peng Bai; Li Rao; Xiao-Wei Su; Tao Wang; Bin Zhou; Yong-Gang Wei; Lin Zhang
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

5.  Glutathione S-transferase polymorphism interactions with smoking status and HPV infection in cervical cancer risk: an evidence-based meta-analysis.

Authors:  Shuai Zhen; Chen-Ming Hu; Li-Hong Bian
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

6.  Semantic integration of cervical cancer data repositories to facilitate multicenter association studies: the ASSIST approach.

Authors:  Theodoros Agorastos; Vassilis Koutkias; Manolis Falelakis; Irini Lekka; Themistoklis Mikos; Anastasios Delopoulos; Pericles A Mitkas; Antonios Tantsis; Steven Weyers; Pascal Coorevits; Andreas M Kaufmann; Roberto Kurzeja; Nicos Maglaveras
Journal:  Cancer Inform       Date:  2009-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.